TY - JOUR
T1 - Adjuvant-induced arthritis induces c-Fos chronically in neurons in the hippocampus
AU - Carter, Jeffrey L.
AU - Lubahn, Cheri
AU - Lorton, Dianne
AU - Osredkar, Tracy
AU - Der, T. C.
AU - Schaller, Jill
AU - Evelsizer, Stephen
AU - Flowers, Schari
AU - Ruff, Natalie
AU - Reese, Bethany
AU - Bellinger, Denise L.
N1 - Chronic pain, sickness behaviors, and cognitive decline are symptoms in rheumatoid arthritis. In the adjuvant-induced arthritis Lewis rat model, we ex...
PY - 2011/1
Y1 - 2011/1
N2 - Chronic pain, sickness behaviors, and cognitive decline are symptoms in rheumatoid arthritis. In the adjuvant-induced arthritis Lewis rat model, we examined the dynamics of c-Fos expression in the hippocampus, a brain region important for these symptoms. Brain sections were stained for c-Fos using immunohistochemistry. c-Fos-positive nuclei were counted in CA1, CA2, CA3 and the dentate gyrus of the dorsal hippocampi from rats receiving no treatment or base-of-the-tail injections of (1 or 2) incomplete or complete Freund's adjuvant (low- or high-dose), (3), Mycobacterium butyricum cell wall suspended in saline, or (4) saline, and sacrificed 4, 14, 21, or 126. days post-immunization. Disease severity was evaluated by dorsoplantar foot pad widths and X-ray analysis. We report sustained dose- and subfield-dependent c-Fos expression with arthritis, but transient expression in nonarthritic groups, suggesting long-term genomic changes in rheumatoid arthritis that may be causal for behavioral changes, adaptation to chronic pain and/or cognitive decline associated with disease.
AB - Chronic pain, sickness behaviors, and cognitive decline are symptoms in rheumatoid arthritis. In the adjuvant-induced arthritis Lewis rat model, we examined the dynamics of c-Fos expression in the hippocampus, a brain region important for these symptoms. Brain sections were stained for c-Fos using immunohistochemistry. c-Fos-positive nuclei were counted in CA1, CA2, CA3 and the dentate gyrus of the dorsal hippocampi from rats receiving no treatment or base-of-the-tail injections of (1 or 2) incomplete or complete Freund's adjuvant (low- or high-dose), (3), Mycobacterium butyricum cell wall suspended in saline, or (4) saline, and sacrificed 4, 14, 21, or 126. days post-immunization. Disease severity was evaluated by dorsoplantar foot pad widths and X-ray analysis. We report sustained dose- and subfield-dependent c-Fos expression with arthritis, but transient expression in nonarthritic groups, suggesting long-term genomic changes in rheumatoid arthritis that may be causal for behavioral changes, adaptation to chronic pain and/or cognitive decline associated with disease.
KW - C-Fos
KW - Hippocampus
KW - Immunohistochemistry
KW - Neural-immune
KW - Rheumatoid arthritis
UR - http://www.scopus.com/inward/record.url?scp=78650966437&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=78650966437&partnerID=8YFLogxK
U2 - 10.1016/j.jneuroim.2010.09.005
DO - 10.1016/j.jneuroim.2010.09.005
M3 - Article
C2 - 20950869
SN - 0165-5728
VL - 230
SP - 85
EP - 94
JO - Journal of Neuroimmunology
JF - Journal of Neuroimmunology
IS - 1-2
ER -